LCN2 and meningeal tuberculosis: In conclusion, our study has suggested that CSF NGAL might be used as an early diagnostic biomarker of BM, especially for differential diagnosis with patients with TBM or CM during the acute periods, and it also might have some important clinical value for monitoring antibiotic therapy for BM.